Journals / Medical Network Klinik Bilimler ve Doktor / 2003 / Cilt: 9 - Sayı: 4

Germ cell ovarian tumors: Our experience of 10 years

Germ hücreli over tümörleri: 10 yıllık deneyimimiz

Pages
499–502
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

But there are still many arguements are carried on topics as second-line surgery and conservative treatment modalities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To transmit the experience of ten years on 39 cases of germ cell tumor of ovary that have been diagnosed and treated in Oncology Department, SSK Teaching and Maternity Hospital.
📊
Key Findings & Data:Materials and Methods: Medical records of 39 cases of malignant germ cell ovarian tumors that have been diagnosed in our hospital were insected retrospectively.
💡
Conclusion & Impact:But there are still many arguements are carried on topics as second-line surgery and conservative treatment modalities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Yumurtalık neoplazmları · Geriyedönük çalışma · Seyir

Abstract

Objective: To transmit the experience of ten years on 39 cases of germ cell tumor of ovary that have been diagnosed and treated in Oncology Department, SSK Teaching and Maternity Hospital. Materials and Methods: Medical records of 39 cases of malignant germ cell ovarian tumors that have been diagnosed in our hospital were insected retrospectively. Main complainments, age, stage, histologic type of tumor, management, and mean follow up time period were the variables that had been studied. Results: Mean age of the cases were 26.5 (range, 15-71). 53.9 % of the cases were sexually active and the rest were not. 79.4% of the tumors were involved unilaterally, and 14.7% were bilaterally. Disgerminomas were the most common histologic type of tumor. This was followed by immature teratomas and endodermal sinus tumors. Conservative surgery was performed in 25 cases and radical cytoreductive surgery was applied on 14 cases. Adjuvant therapy was applied in 38 cases. 1 case was managed both radio-chemotherapy. Second line surgery was performed in18 cases. Mean follow up time period was 39 months (range, 4-142). Second-line chemotherapy were carried on 11 cases because of tumor currence. 2 cases died during treatment because of tumor progression. Conclusion: Germ cell ovarian tumors are the cancer of young women that can be diagnosed in earlier stages than epitelial tumors of ovary. Tumor involvements are usually limited to unilateral site of ovaries. Fertility preserving conservative surgery can be usually performed because of the fine response to chemotherapy. But there are still many arguements are carried on topics as second-line surgery and conservative treatment modalities.

Özet

Amaç: SSK Ege Doğumevi ve Kadın Hastalıkları Eğitim Hastanesi Onkoloji Bölümünde tedavi edilen 39 malign germ hücreli over tümörü olgusunun kayıtları retrospektif incelenmesiyle 10 yıllık deneyimimizi aktarmaktır. Gereç ve Yöntem: 1991-2001 yılları arasında hastanemiz Onkoloji Departmanında tanı alan veya tedavi görmekte olan 39 malign germ hücreli over tümörü olgusunun kayıtları geriye dönük incelendi. Olguların geliş yakınması, yaşı, evre, tümörün histolojik özellikleri, tedavi şekli, ve ortalama takip süreleri araştırıldı. Bulgular: Olguların yaş ortalaması 26.5 (15-71)'di. Olguların %53.9'u seksüel açıdan inaktif, %46.1'i ise aktifdi. Preoperatif 34 olguya görüntüleme yöntemleri eşliğinde inceleme yapıldı. Bu olguların %79.4'ünde unilateral, %14.7'sinde bilateral adneksiyal kitle saptandı. Postoperatif bilateral adneksiyal kitle saptanma oranı ise %17.6 idi. Histopatolojik inceleme sonucunda ilk sırada disgerminom, ikinci sırada immatur teratom, ve 3, sırada endodermal sinüs tümörleri izlendi. 25 olguya organ koruyucu cerrahi tedavi ve 14 olguya radikal sitoredüktif cerrahi tedavi uygulandı. Olguların %70.5'i evre I, %14.7'si ise evre II ve III idi. %97.4 olguya cerrahi tedavi sonrası adjuvan tedavi verildi. 1 olgu adjuvan tedavi olarak radyoterapi ve kemoterapiyi kombine aldı. 18 ileri evre olguya (%46.1) ikinci bakış cerrahisi uygulandı. Tedavi sonrası ortalama takip süresi 39 ay (4-142) olan olgularımızın 11 tanesinde (%28.2) nüks tümör izlendi. Bu 11 olguya ikinci kez kemoterapi verildi. Tedavileri esnasında iki olgu t ümör progresyonu nedeniyle kaybedildi. Sonuç: Germ hücreli over tümörleri, epitelyal over tümörlerine kıyasla erken evrelerde tanısı koyulabilen genç yaş grubundaki kadınların hastalığıdır. Tümör tutulumu genellikle unilateraldir. Kemoterapiye hassas olmaları nedeniyle koruyucu cerrahi tedavi ve fertilitenin korunması için uygun kanserlerdir. Bununla birlikte ikinci bakış laparatomisinin yeri ve ileri evrede organ koruyucu cerrahi tedavileri konularında halen tartışmalar devam etmektedir.

🔖

Cite This Article

KURT, S., BAŞOĞUL, N., ALİHANOĞLU, M., CAMUZCUOĞLU, H., PİLANCI, B., TINAR, Ş., SAYHAN, S., HANHAN, M., ÇOLAK, E. (2003). Germ cell ovarian tumors: Our experience of 10 years. Medical Network Klinik Bilimler ve Doktor, Cilt: 9 - Sayı: 4, 499–502. https://ajindex.com/articles/278588

References (11)

  1. Berek JS, Fu YS, Hacker NF. Ovarian cancer. In: Berek JS, Adashi EY; Hillard PA. eds. Novak Jinekoloji. Baltimore: Willams&Wilkins, 1996:1155-231. Scully RE. Tumors of the ovary and maldeveloped gonads. Armed Forces Institute of Pathology, 1979; 16:121-9.
  2. Germa JR, Izquiero MA, Climent MA, Ojeda B, Alonjo C. Ma­lignant Ovarian Germ Cell Tumors. The Experience at the Hos­pital de la Sante Creu I Sant Pau. Gynecol Oncol 1992; 45:153-9.
  3. Parker SL, Tong T, Bolden S, Wingo PA. Cancer stastics, 1996. CA-Cancer J Clin 1996; 65:5-27.
  4. Grischke EM, Wallwiener D, Bastert G. Charecteristics of rare ovarian tumors possibi lities of organ preservation. Zentralbl Gynakol 1996; 118:322-5.
  5. Willemse PHB, De Vries EGE, Mulder NH, Aalders JG, Bouma J, Sleijfer DT. in transperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer. Eur J Cancer 1990; 26:353-8.
  6. Demirkıran F, Beşe T, Arvas M, et al. Överin Malign Germ Hücreli Tümörleri: 12 Yıllık Deneyim. Jinekolojik Onkoloji Dergisi 2001;4:23-8.
  7. Low JJ, Perrin Lc, Crandon AJ, Hacker NF. Conservative surgery to preserve ovarian function in patents with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 2000; 89:391-8.
  8. Bafna UD, Umadevi K, Kumaran C, Nagarathna DS, Shashikale P, Tanseem R. Germ cell tumors of the ovary: is there a ro­le for aggressive cytoreductive surgery for nondysgerminomo-tous tumors?. Int J Gynecol Cancer; 1997 11:300-4. Schwartz PE. Surgery of germ cell tumours of the ovary. Forum (genova) 2000; 10:355-65.
  9. Perrin LC, Low J, Nicklin JL, Ward BG, Crandon AJ. Fertility and ovarian function after conservative surgery for germ cell tumours of the ovary. Obstet Gynaecol. 1999; 39:243-5.
  10. Zanetta G, Chiari S, Rota S, et al. Conservative Surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 1997; 104:1030-5.
  11. Ushijima K, Nishida T, Yakushiji M. Assessment of second-look operations in malignant ovarian germ cell tumors. Int J Gynecol Obstet 1998; 60:291. Ayhan A, Tuncer S, Yanık F, Bükülmez O, Yanık A, Küçükali T. Malignant germ cell tumors of the ovary: Hacettepe hospital experience. Acta Obstet Gynecol Scand 1995; 74:384. Culine S, Lhomme C, Kattan J, et al. Cisplatin-based Che-motheraphy in the management of germ cell tumors of the o-vary: The Institut Gustave Roussy Experience. Gynecol Oncol 1997; 64:160. Wu PC, Huang RL, Lang JH, Tang MY. Treatment of malignant ovarian germ cell Tumors with preservation of fertility: A report of 28 cases. G